Media Room

Transmission models of COVID-19 are used by policymakers and hospital leaders to inform disease prevention and mitigation activities and prepare for case surges.

SARS-CoV-2, the virus that causes COVID-19, ignites an immune response to infection, which results in severe lung inflammation.

Social distancing can help deter some of COVID-19’s spread, but the development of a vaccine is the only surefire way to combat this devastating disease.

The COVID-19 outbreak has crystallized the urgent need for therapeutics to better prevent transmission in human populations.

Using both commercial reference material and potential clinical samples from the University of Minnesota Medical School, Lions Gift of Sight, and Veterinary Medical Center, a team of researchers led by Declan Schroeder, PhD, will convert a targeted next-generation sequencing approach (that was developed in-house) to sequence SARS-CoV-2, the virus that causes COVID-19.

The ability to detect antibodies against a SARS-CoV-2 infection presents a tremendous opportunity for the development of a COVID-19 diagnostic test.

SARS-CoV-2, the virus that causes COVID-19, uses its spike protein to recognize the receptor ACE2 on human lung cells, attaching the virus to the cells.

Montserrat Torremorell, DVM, PhD, is collaborating with researchers both within the CVM and at the College of Science and Engineering to test whether air purifying systems can inactivate airborne coronaviruses.

Coronaviruses infect humans by binding to specific proteins, known as receptors, on human cell surfaces.

Meggan Craft, PhD, associate professor in the Department of Veterinary Population Medicine is collaborating with Eva Enns, PhD, associate professor in the Division of Health Policy and Management in the School of Public Health, to create a model of how the novel coronavirus moves through an individual’s network.